While the specific NDC 00597-0385 is not provided in the sources, we can analyze the market and price trends for a similar drug, MIRAPEX (NDC 00597-0287), to draw some insights that might be applicable.
Drug Overview
MIRAPEX, with the NDC 00597-0287, is a medication manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. It is used primarily for the treatment of Parkinson's disease and restless legs syndrome.
Market Context
The pharmaceutical market, particularly for drugs like MIRAPEX, is influenced by several factors including regulatory changes, technological advancements, and market demand.
General Market Growth
The overall prescription drug market is expected to grow at a CAGR of 9% through 2030, driven by advancements in biopharmaceuticals and biotechnology[2].
Biopharma and Biotech Sector Growth
The biopharma market size was estimated to be over $400 billion in 2024, with a projected CAGR of 7.56% between 2024 and 2029. The biotech sector, with a market size of nearly $500 billion in 2020, is expected to grow at a CAGR of 9.4% between 2021 and 2027[3].
Price Trends for MIRAPEX (NDC 00597-0287)
Current Pricing
As of the latest data, the prices for MIRAPEX 3.75MG TAB ER (NDC 00597-0287) vary based on the pricing type and vendor:
- Big4 Pricing: The price per unit ranges from $14.50 to $17.34, with a total price for a 30-count package ranging from $434.96 to $520.34[1].
- FSS (Federal Supply Schedule) Pricing: The price per unit is around $22.73, with a total price for a 30-count package being $682.00[1].
Price Projections
Given the general trend in the pharmaceutical market, here are some projections:
Impact of Market Growth
The growth in the biopharma and biotech sectors is likely to influence the pricing of drugs like MIRAPEX. As the market expands, there could be increased competition, which might stabilize or reduce prices.
Regulatory and Technological Factors
Accelerated clinical trial designs and evolving regulatory frameworks could lead to more efficient drug development and potentially lower costs. However, the adoption of new technologies, such as precision medicine and AI/ML, might also increase costs in the short term[3].
Generic and Biosimilar Impact
The expiration of patents for blockbuster drugs can lead to the introduction of generics and biosimilars, which typically reduce prices. However, since MIRAPEX is not mentioned in the context of patent expirations, its pricing might not be directly affected by this factor[4].
Key Factors Influencing Pricing
Clinical Trial Innovations
Innovative clinical trial designs can reduce the time and cost associated with drug development, potentially leading to lower prices for patients[3].
Regulatory Changes
Evolving regulatory frameworks can impact the approval and pricing of drugs. For instance, changes in the NDC number structure due to the FDA running out of numbers could have systemic impacts on the pharmaceutical supply chain, though this is more about infrastructure than direct pricing[5].
Market Demand and Competition
The demand for Parkinson's disease and restless legs syndrome treatments, along with the presence of competitors, will influence the pricing strategy for MIRAPEX.
Conclusion
While specific data for NDC 00597-0385 is not available, the analysis of MIRAPEX (NDC 00597-0287) suggests that the pricing will be influenced by broader market trends, regulatory changes, and technological advancements.
Key Takeaways
- The pharmaceutical market is expected to grow significantly through 2030.
- Biopharma and biotech sectors are driving this growth with high CAGRs.
- Pricing for drugs like MIRAPEX can be affected by market growth, regulatory changes, and technological innovations.
- The introduction of generics and biosimilars can reduce prices, but this is not directly applicable to MIRAPEX based on available data.
FAQs
What is the current market size of the biopharma sector?
The biopharma market size was estimated to be over $400 billion in 2024[3].
How is the pharmaceutical market expected to grow?
The overall prescription drug market is expected to grow at a CAGR of 9% through 2030[2].
What factors influence the pricing of drugs like MIRAPEX?
Pricing is influenced by market growth, regulatory changes, technological innovations, and the introduction of generics and biosimilars[1][3][4].
How do clinical trial innovations impact drug pricing?
Innovative clinical trial designs can reduce the time and cost associated with drug development, potentially leading to lower prices for patients[3].
What is the impact of NDC number changes on the pharmaceutical industry?
Changes in the NDC number structure could have systemic impacts on the pharmaceutical supply chain, similar to the Y2K issue, but this is more about infrastructure than direct pricing[5].
Sources
- DrugPatentWatch - Latest drug prices and trends for NDC 00597-0287.
- DrugPatentWatch - Latest drug prices and trends for NDC 00054-0319.
- TFS CRO - 5 Predictions for the Biopharma and Biotech Industries in 2025.
- Drug Development - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
- Wolters Kluwer - Are You Prepared for a Major Industry Change to the National Drug Code (NDC) Number?
